Logo

Vanderbilt-Ingram Joins Open Biosystems' Open Access Program

Sep 11, 2006

NEW YORK (GenomeWeb News) – Open Biosystems said today that Vanderbilt-Ingram Cancer Center has joined its Open Access program for RNAi and cDNA products. 

Open Biosystems said the program gives the cancer center access to its whole-genome lentiviral human and mouse shRNAmir libraries for RNAi, as well as the company’s mammalian gene cDNA collection. Under the program, researchers throughout Vanderbilt-Ingram can share Open Biosystems’ technology, and will have access to continual library updates and upgrades.

Terms of the deal were not disclosed.

 

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.